Study guide
1.2 Cardiovascular Anatomy & Cardiac Conduction System
Certified Biomedical Equipment Technician CBET
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Medical Terminology & Cardiovascular Physiology
1.1 Medical Terminology, Prefixes, Suffixes & Anatomical Directions 1.2 Cardiovascular Anatomy & Cardiac Conduction System 1.3 Hemodynamics, Perfusion & Blood Pressure Calculations 1.4 Electrocardiography (ECG) Waveforms, Vectors & Lead Systems
2 Chapter 2: Respiratory, Nervous, Musculoskeletal & Organ Systems
2.1 Respiratory Anatomy, Mechanics of Breathing & Gas Exchange 2.2 Nervous System, Neuromuscular Junction & Electrophysiology 2.3 Renal Filtration, Gastrointestinal & Endocrine Systems
3 Chapter 3: Basic Electrical Theory & DC Circuit Analysis
3.1 Fundamental Electrical Laws, Ohm's Law & Power Calculations 3.2 DC Circuit Analysis, Kirchhoff's Laws & Bridge Circuits 3.3 Capacitors, Inductors & RC/RL Transient Analysis
4 Chapter 4: AC Circuits, Semiconductor Devices & Analog/Digital Electronics
4.1 AC Waveforms, RMS, Reactance & Total Impedance 4.2 Diodes, Rectifiers, Linear/Switching Power Supplies & Transistors 4.3 Operational Amplifiers, Active Filters & Instrumentation Bioamplifiers 4.4 Digital Logic Gates, Flip-Flops, ADC/DAC & Nyquist Sampling
5 Chapter 5: Clinical Networking & Infrastructure
5.1 Networking Fundamentals, OSI Model & IPv4/IPv6 Subnetting 5.2 Network Hardware, Structured Cabling & Clinical Topologies 5.3 Hospital Wi-Fi Standards & Wireless Medical Telemetry (WMTS)
6 Chapter 6: Interoperability, Cybersecurity & Connected Medical Devices
6.1 Medical Device Interoperability: HL7, FHIR, DICOM & Gateways 6.2 Healthcare Cybersecurity, MDS2, Patching & Legacy OS Hardening 6.3 Network Segmentation, VLANs, Zero Trust & IoMT Security 6.4 Troubleshooting Clinical System Hardware, Peripherals, Storage & Cable Plant
7 Chapter 7: Healthcare Electrical Safety & Facility Standards
7.1 NFPA 99 Health Care Facilities Code & Receptacle Grounding 7.2 Medical Device Leakage Current, IEC 60601-1 & Applied Parts (B/BF/CF) 7.3 Operating Room Isolated Power Systems & Line Isolation Monitors (LIM)
8 Chapter 8: Environmental Safety, Infection Control & Regulatory Compliance
8.1 Hospital Safety, OSHA HazCom, Fire Extinguishers & Medical Gas Systems 8.2 Infection Control, CDC Precautions, Spaulding Disinfection & PPE in HTM 8.3 Healthcare Accreditation (TJC EC), CMS CoP & FDA SMDA/MedWatch Reporting
9 Chapter 9: Physiological Monitoring & Diagnostic Modalities
9.1 Multi-Parameter Patient Monitors & ECG Signal Processing 9.2 Blood Pressure (NIBP/IBP Transducers) & SpO2 Pulse Oximetry 9.3 Capnography (EtCO2), Temperature Measurement & Neurodiagnostics (EEG/EMG) 9.4 Diagnostic Equipment (Otoscope, Ophthalmoscope, Audiometer, Spirometer, Scales, Stress Test) & Clinical Measurement Units 9.5 Fetal Monitoring: Ultrasound FHR Transducers, Tocodynamometry (TOCO), Internal Leads & Maternal-Fetal Telemetry
10 Chapter 10: Therapeutic, Surgical & Life-Support Equipment
10.1 Infusion Pumps, Syringe Pumps & Medication Delivery Safety 10.2 Defibrillators, Biphasic Waveforms, Cardioversion & Pacemakers 10.3 Mechanical Ventilators & Anesthesia Delivery Systems 10.4 Electrosurgical Units (ESU), Return Electrode Monitoring & Surgical Lasers 10.5 Perioperative Support Equipment: Pneumatic Tourniquets, Surgical Tables, Lights, Microscopes, Video Integration & Fluid Warmers 10.6 Intra-Aortic Balloon Pumps, Aspiration/Suction Systems, Neonatal Therapeutic Devices & Physical Therapy Modalities
11 Chapter 11: Laboratory, Sterilization & Biomedical Test Instrumentation
11.1 Laboratory Centrifuges, Analyzers & Patient Thermal Management 11.2 Steam Autoclaves, Sterilization Methods & Biological Indicators 11.3 Specialized Biomedical Test Equipment, Simulators & NIST Traceability 11.4 Histology & Cold-Chain Laboratory Equipment: Cryostats, Microtomes, Rockers, Water Baths, Refrigerators, Freezers & Microscopes
12 Chapter 12: Troubleshooting Methodologies & Monitoring Systems Repair
12.1 Systematic Troubleshooting Principles & Signal Tracing Methods 12.2 Troubleshooting Patient Monitors, ECG Artifacts & Sensor Faults 12.3 Troubleshooting Infusion Devices, Occlusions & Air Detection 12.4 Device Error vs. Use Error, Repair Prioritization & Clinical Staff Education
13 Chapter 13: Troubleshooting Life-Support, OR & Clinical IT Systems
13.1 Troubleshooting Defibrillators, Pacing & High-Voltage Discharge 13.2 Troubleshooting Ventilators, Gas Blenders & Flow Transducers 13.3 Troubleshooting Electrosurgical Generators & REM Circuit Faults 13.4 Troubleshooting Clinical Telemetry, Wireless & Gateway Interfaces 13.5 Troubleshooting Diagnostic & Therapeutic Equipment 13.6 Troubleshooting Laboratory & Perioperative Equipment
14 Chapter 14: Healthcare Technology Management (HTM) & Quality Assurance
14.1 Medical Equipment Management Plan (MEMP) & CMS AEM Programs 14.2 CMMS Work Order Management, Asset Lifecycle & HTM Metrics (MTBF/MTTR) 14.3 Calibration Quality Assurance, Documentation & Return to Service Protocols 14.4 ANSI/AAMI EQ56, EQ89, EQ93 & EQ103: The HTM Standards Framework
15 Chapter 15: CBET Exam Readiness — Blueprint, Eligibility & Logistics
15.1 The Official CBET Content Outline, Eligibility Pathways & Application Process 15.2 Test Day, Scoring, Results & Maintaining the CBET Credential
1.2 Cardiovascular Anatomy & Cardiac Conduction System
Key Takeaways Explain This Topic AI
The human heart consists of four muscular chambers: two thin-walled low-pressure atria (RA and LA) that receive venous return, and two muscular high-pressure ventricles (RV and LV) that pump blood into pulmonary and systemic circulations.
Blood flows unidirectionally through four fibrous valves: two atrioventricular valves (Tricuspid on the right, Mitral/Bicuspid on the left) and two semilunar valves (Pulmonary and Aortic).
The intrinsic cardiac conduction hierarchy comprises the SA node (60–100 bpm), AV node (delay 0.04–0.12 s, intrinsic 40–60 bpm), Bundle of His, bundle branches, and Purkinje fibers (20–40 bpm).
The ventricular cardiac action potential has five distinct phases: Phase 0 (rapid Na+ influx depolarization), Phase 1 (transient repolarization), Phase 2 (plateau Ca2+ influx balancing K+ efflux), Phase 3 (rapid K+ efflux repolarization), and Phase 4 (resting membrane potential -90 mV maintained by Na+/K+ ATPase).
Synchronized cardioversion must detect the R-wave peak to discharge electrical energy safely away from the vulnerable T-wave repolarization window, preventing fatal R-on-T ventricular fibrillation.
Last updated: August 2026
Cardiovascular Anatomy & Cardiac Conduction System
The cardiovascular system is the primary hemodynamic transport network of the human body, delivering oxygenated blood, glucose, electrolytes, and hormones to peripheral tissues while removing carbon dioxide and metabolic byproducts. For the Biomedical Equipment Technician, the heart represents both a high-reliability dual hydraulic pump and an autonomous bioelectric pulse generator .
Mastery of cardiovascular anatomy, hemodynamic circulation pathways, coronary perfusion, and electrophysiological conduction kinetics is indispensable for installing, maintaining, and calibrating life-critical devices including multi-parameter patient monitors, external pacemakers, automated and manual defibrillators, and intra-aortic balloon pumps (IABP).
1. Gross Cardiac Anatomy: The Four Chambers & Pericardial Architecture
The human heart is a hollow, muscular organ located in the middle mediastinum of the thoracic cavity, oriented obliquely with its base facing superiorly, posteriorly, and to the right, and its apex pointing inferiorly, anteriorly, and to the left (directly behind the fifth intercostal space at the midclavicular line). +-----------------------------------------------------------------------------+
- | SCHEMATIC OF CARDIAC CHAMBERS |
- | |
- | [SUPERIOR / INFERIOR VENA CAVA] |
- | | |
- | v |
- | +---------------------+ |
- | | RIGHT ATRIUM (RA) | |
- | | (Press: 2-6 mmHg) | |
- | +----------+----------+ |
- | | (Tricuspid Valve) |
- | v |
- | +---------------------+ (Pulmonary Valve) |
- | | RIGHT VENTRICLE(RV) | ------------------------> [LUNGS]|
- | | (Press: 25/0-8 mmHg)| | |
- | +---------------------+ | |
- | | |
- | [SYSTEMIC +---------------------+ (Mitral Valve) | |
- | CIRCULATION] <--| LEFT VENTRICLE (LV) | <--------------------+ | |
- | ^ | (Press: 120/3-12) | | | |
- | | +---------------------+ | | |
- | | ^ | | |
- | (Aortic Valve) | +----------+---------+ |
- | | | LEFT ATRIUM (LA) | |
- | +----------------------| (Press: 4-12 mmHg)|<+
- | +--------------------+
- | ^
- | | (4 Pulm. Veins)
- +-----------------------------------------------------------------------------+
- The Cardiac Wall & Pericardium
The heart wall is composed of three distinct tissue layers encapsulated by a fibroserous sac:
Epicardium (Visceral Pericardium): The smooth, outer serous epithelial layer containing coronary blood vessels, lymphatic vessels, and epicardial fat.
Myocardium: The thick middle layer composed of specialized, striated, branching cardiac myocytes joined by intercalated discs containing gap junctions. Gap junctions provide low-resistance electrical pathways, enabling the myocardium to function as an electrical functional syncytium .
Ventricular Asymmetry: The Left Ventricle (LV) myocardium is 3 to 4 times thicker ( 8 – 12 mm 8\text{--}12\text{ mm} 8 – 12 mm ) than the Right Ventricle (RV) wall ( 3 – 5 mm 3\text{--}5\text{ mm} 3 – 5 mm ) because the LV must generate sufficient hydrostatic pressure ( 100 – 140 mmHg 100\text{--}140\text{ mmHg} 100 – 140 mmHg ) to overcome high Systemic Vascular Resistance (SVR), whereas the RV only pumps against low Pulmonary Vascular Resistance (PVR, systolic 15 – 25 mmHg 15\text{--}25\text{ mmHg} 15 – 25 mmHg ).
Endocardium: The smooth, innermost endothelial lining that covers the chamber cavities, trabeculae carneae, and cardiac valve leaflets, preventing thrombus formation.
Pericardial Sac (Parietal Pericardium & Fibrous Pericardium): Surrounds the heart. The pericardial cavity between parietal and visceral layers contains 15 – 50 mL 15\text{--}50\text{ mL} 15 – 50 mL of lubricating serous fluid. Rapid accumulation of fluid (e.g., hemorrhage from trauma or aortic dissection) causes Cardiac Tamponade , restricting ventricular diastolic filling and resulting in catastrophic circulatory collapse.
2. Heart Valves & Hemodynamic Regulation
Four non-muscular, fibrous valves enforce strict unidirectional forward blood flow. Valve opening and closure are entirely passive, driven by hydrostatic pressure gradients across the chambers. +-----------------------------------------------------------------------------+
- | CARDIAC VALVE CHARACTERISTICS |
- | |
- | ATRIOVENTRICULAR (AV) VALVES SEMILUNAR (SL) VALVES |
- | - Located between Atria & Ventricles - Located between Ventricles & |
- | - Anchored by Chordae Tendineae to Great Arteries |
- | Papillary Muscles - Pocket-like crescent cusps |
- | - Close at onset of Systole (S1) - Close at onset of Diastole (S2)|
- | |
- | 1. TRICUSPID VALVE (Right Side) 1. PULMONARY VALVE (Right Side) |
- | 3 Cusps: Anterior, Posterior, Septal 3 Cusps: Ant, Right, Left |
- | 2. MITRAL / BICUSPID VALVE (Left Side) 2. AORTIC VALVE (Left Side) |
- | 2 Cusps: Anterior, Posterior 3 Cusps: Right, Left, Post. |
- +-----------------------------------------------------------------------------+
- Atrioventricular (AV) Valves
Tricuspid Valve: Situated between the Right Atrium and Right Ventricle; composed of three fibrous cusps (anterior, posterior, septal).
Mitral (Bicuspid) Valve: Situated between the Left Atrium and Left Ventricle; composed of two robust cusps (anterior and posterior). The mitral valve experiences the highest mechanical and pressure stress in the body during ventricular systole.
Subvalvular Apparatus: Both AV valves are tethered to ventricular papillary muscles via fibrous collagenous cords called chordae tendineae ("heart strings"). During ventricular systole, papillary muscles contract simultaneously with the myocardium, exerting tensile force on the chordae tendineae to prevent the valve cusps from prolapsing (eversion) into the atria under high ventricular systolic pressure.
Semilunar (SL) Valves
Pulmonary Semilunar Valve: Positioned at the exit of the Right Ventricle into the pulmonary trunk; consists of three crescent-shaped cusps.
Aortic Semilunar Valve: Positioned at the exit of the Left Ventricle into the ascending aorta; consists of three pocket-like cusps (right coronary, left coronary, and non-coronary cusps). Behind the right and left cusps lie the Sinuses of Valsalva , from which the coronary arteries originate.
Auscultatory Heart Sounds & Acoustic Transducer Calibration
First Heart Sound ( S 1 S_1 S 1 , "Lub"): Produced by the sudden deceleration of blood and closure of the Tricuspid and Mitral (AV) valves immediately following the onset of ventricular systole (coinciding with the peak of the QRS complex on the ECG).
Second Heart Sound ( S 2 S_2 S 2 , "Dub"): Produced by the rapid closure of the Aortic and Pulmonary (SL) valves at the end of ventricular systole / beginning of ventricular diastole (coinciding with the end of the T wave).
3. Complete Blood Flow Pathway: Pulmonary & Systemic Circuits
The cardiovascular system operates two closed loops in series: the Pulmonary Circulation (low-pressure, oxygen-absorbing loop) and the Systemic Circulation (high-pressure, oxygen-delivering loop). +-----------------------------------------------------------------------------+
- | COMPLETE SYSTEMIC & PULMONARY BLOOD FLOW |
- | |
- | [1. SYSTEMIC VENOUS RETURN] (Deoxygenated: SvO2 ~70-75%, PaO2 ~40 mmHg) |
- | Superior & Inferior Vena Cava + Coronary Sinus |
- | | |
- | v |
- | [2. RIGHT ATRIUM] -------------> (Tricuspid Valve) |
- | | |
- | v |
- | [3. RIGHT VENTRICLE] ----------> (Pulmonary Semilunar Valve) |
- | | |
- | v |
- | [4. PULMONARY TRUNK & ARTERIES] (Deoxygenated blood to Left/Right Lungs) |
- | | |
- | v |
- | [5. ALVEOLAR CAPILLARIES] -----> (Gas Exchange: O2 absorbed, CO2 exhaled) |
- | | |
- | v |
- | [6. FOUR PULMONARY VEINS] (Oxygenated: SaO2 98-100%, PaO2 ~95-100 mmHg) |
- | | |
- | v |
- | [7. LEFT ATRIUM] --------------> (Mitral / Bicuspid Valve) |
- | | |
- | v |
- | [8. LEFT VENTRICLE] -----------> (Aortic Semilunar Valve) |
- | | |
- | v |
- | [9. ASCENDING AORTA & SYSTEMIC ARTERIAL TREE] |
- | | |
- | v |
- | [10. SYSTEMIC CAPILLARIES] ----> (Tissue O2 delivery & CO2 pickup) |
- | | |
- | +-----> Returns to Step 1 (Vena Cava) |
- +-----------------------------------------------------------------------------+
Important
Critical Clinical Distinction: The Pulmonary Artery is the only adult artery carrying deoxygenated blood away from the heart, while the Pulmonary Veins are the only adult veins carrying oxygenated blood back to the heart.
4. Coronary Arterial Circulation & Myocardial Infarction
The myocardium does not absorb oxygen directly from blood inside its chambers. Instead, it is supplied by its own high-flow vascular network—the Coronary Arteries —which branch off the root of the aorta immediately distal to the aortic valve cusps. +-----------------------------------------------------------------------------+
- | CORONARY CIRCULATION TAXONOMY |
- | |
- | [ROOT OF ASCENDING AORTA] |
- | | |
- | +--------------------+--------------------+ |
- | | | |
- | v v |
- | [LEFT CORONARY ARTERY (LCA)] [RIGHT CORONARY ARTERY (RCA)] |
- | (Left Main Stem) - Supplies RA, RV, inferior LV|
- | | - SA Node branch (60% people) |
- | +--------+--------+ - AV Node branch (90% people) |
- | | | - Posterior Descending (PDA) |
- | v v |
- | [LEFT ANTERIOR [CIRCUMFLEX (LCx)] |
- | DESCENDING (LAD)]- Supplies LA, lateral |
- | - Anterior LV wall and posterior LV wall |
- | - Anterior 2/3 of |
- | interventricular |
- | septum, bundles |
- | - "Widow Maker" |
- +-----------------------------------------------------------------------------+
Electrophysiological Consequences of Coronary Occlusion:
LAD Occlusion: Precipitates massive anterior/septal wall Myocardial Infarction (MI), leading to Bundle Branch Blocks (wide QRS > 0.12 s >0.12\text{ s} > 0.12 s ), acute cardiogenic shock, and ventricular fibrillation.
RCA Occlusion: Precipitates inferior wall MI; damages the SA and AV nodes, frequently resulting in severe sinus bradycardia, high-grade AV blocks (Mobitz II, 3rd-degree complete heart block), and sudden junctional escape rhythms.
5. The Intrinsic Cardiac Conduction System
The heart possesses intrinsic autorhythmicity: specialized cardiac myocytes generate and conduct electrical impulses spontaneously without requiring external neural stimulation from the autonomic nervous system. +-----------------------------------------------------------------------------+
- | CARDIAC CONDUCTION HIERARCHY & VELOCITIES |
- | |
- | [1. SINOATRIAL (SA) NODE] -------------------------> Conduction: 0.05 m/s |
- | Location: Superior Posterolateral RA wall Intrinsic: 60-100 bpm|
- | | |
- | +---> Internodal Pathways (Bachmann, Wenckebach, Thorel) |
- | | |
- | v |
- | [2. ATRIOVENTRICULAR (AV) NODE] --------------------> Conduction: 0.02 m/s |
- | Location: Posteroinferior Interatrial Septum Intrinsic: 40-60 bpm|
- | *CRITICAL DELAY:* 0.04 to 0.12 seconds (PR Segment) |
- | | |
- | v |
- | [3. BUNDLE OF HIS (AV BUNDLE)] ---------------------> Conduction: 1.5 m/s |
- | Penetrates fibrous cardiac skeleton |
- | | |
- | v |
- | [4. RIGHT & LEFT BUNDLE BRANCHES] ------------------> Conduction: 2.0 m/s |
- | Descend interventricular septum (Left divides |
- | into Anterior & Posterior Fascicles) |
- | | |
- | v |
- | [5. PURKINJE FIBER NETWORK] ------------------------> Conduction: 4.0 m/s |
- | Subendocardial ventricular distribution Intrinsic: 20-40 bpm|
- | Rapid synchronous depolarization from Apex to Base |
- +-----------------------------------------------------------------------------+
The Pacemaker Hierarchy & Escape Mechanisms:
Primary Pacemaker (SA Node): Governs normal sinus rhythm at 60 – 100 bpm 60\text{--}100\text{ bpm} 60 – 100 bpm due to the fastest rate of spontaneous Phase 4 diastolic depolarization.
Secondary / Latent Pacemaker (AV Node / AV Junction): Assumes pacing control at 40 – 60 bpm 40\text{--}60\text{ bpm} 40 – 60 bpm if the SA node fails, slows pathologically, or if an exit block occurs.
Tertiary / Escape Pacemaker (Purkinje Fibers / Ventricles): Generates ventricular escape rhythms at 20 – 40 bpm 20\text{--}40\text{ bpm} 20 – 40 bpm with wide, bizarre QRS complexes ( > 0.12 s >0.12\text{ s} > 0.12 s ) if supranodal conduction is completely severed (3rd-degree complete AV block).
The Physiological Role of the AV Nodal Delay:
The AV node slows electrical conduction velocity to ∼ 0.02 – 0.05 m/s \sim 0.02\text{--}0.05\text{ m/s} ∼ 0.02 – 0.05 m/s , producing an intentional delay of 0.04 to 0.12 seconds 0.04\text{ to }0.12\text{ seconds} 0.04 to 0.12 seconds (reflected in the PR segment on the surface ECG). This delay serves two vital clinical functions:
Allows complete mechanical contraction of the atria ("atrial kick") to finish filling the ventricles prior to ventricular systole.
Acts as an electrical low-pass frequency filter, blocking excessively rapid atrial impulses (such as in Atrial Fibrillation with atrial rates of 350 – 600 bpm 350\text{--}600\text{ bpm} 350 – 600 bpm ) from conducting 1 : 1 1:1 1 : 1 to the ventricles and inducing lethal ventricular tachycardia.
6. Cellular Electrophysiology: The Ventricular Action Potential
Unlike skeletal muscle, the non-pacemaker cardiac ventricular myocyte exhibits a prolonged action potential lasting 200 – 300 ms 200\text{--}300\text{ ms} 200 – 300 ms , featuring a distinctive plateau phase that prevents sustained tetanic contraction and guarantees cyclic mechanical pumping. +-----------------------------------------------------------------------------+
- | VENTRICULAR MYOCYTE ACTION POTENTIAL PHASES |
- | |
- | +20 mV + [Phase 1: Rapid Early Repolarization (Ito)] |
- | | /\ |
- | 0 mV + / \=======[Phase 2: Plateau (ICa,L vs IKr/IKs)]========\
- | | / \
- | -40 mV + [Ph 0: Fast Na+] \[Ph 3: Rapid K+]|
- | | / \
- | -70 mV + / (Threshold) \
- | | / \
- | -90 mV +=+====================================================================+==
- | [Phase 4: Resting Membrane Potential (IK1, Na+/K+ ATPase Pump)] |
- | |<------------ Absolute Refractory Period (ARP) -------------->||
- +-----------------------------------------------------------------------------+
- Detailed Analysis of the 5 Action Potential Phases
Phase Electrophysiological Event Primary Ion Channels & Driving Forces Clinical / BMET Correlation
Phase 0 ; (Rapid Depolarization) Fast inward positive charge transition; V m V_m V m shoots from − 90 mV -90\text{ mV} − 90 mV to + 20 mV +20\text{ mV} + 20 mV in < 2 ms <2\text{ ms} < 2 ms . Voltage-gated Fast N a + Na^+ N a + Channels open rapidly; massive influx of sodium ( I N a I_{Na} I N a ) down electrical and concentration gradients. Corresponds directly to the QRS complex on the surface ECG. Class I antiarrhythmic drugs (lidocaine, procainamide) block fast N a + Na^+ N a + channels, slowing Phase 0.
Phase 1 ; (Early Rapid Repolarization) Brief partial repolarization down to ∼ 0 mV \sim 0\text{ mV} ∼ 0 mV . Fast N a + Na^+ N a + channels abruptly inactivate; transient outward potassium current ( I t o I_{to} I t o ) activates briefly. Defines the sharp notch at the peak of the action potential preceding the plateau.
Phase 2 ; (Plateau Phase) Prolonged isoelectric plateau lasting 100 – 150 ms 100\text{--}150\text{ ms} 100 – 150 ms ; membrane potential remains near 0 mV 0\text{ mV} 0 mV . Balance between inward C a 2 + Ca^{2+} C a 2 + current through voltage-gated L-type Calcium Channels ( I C a , L I_{Ca,L} I C a , L ) and outward K + K^+ K + current ( I K r , I K s I_{Kr}, I_{Ks} I Kr , I Ks ). Inward C a 2 + Ca^{2+} C a 2 + triggers Ryanodine Receptor (RyR2) Calcium-Induced Calcium Release (CICR) from the sarcoplasmic reticulum, powering muscle contraction. Corresponds to the ST segment on ECG.
Phase 3 ; (Rapid Repolarization) Accelerating repolarization restoring negative intracellular polarity from 0 mV 0\text{ mV} 0 mV back to − 90 mV -90\text{ mV} − 90 mV . Inactivation of L-type C a 2 + Ca^{2+} C a 2 + channels; massive efflux of potassium through delayed rectifier K + K^+ K + channels ( I K r , I K s I_{Kr}, I_{Ks} I Kr , I Ks ). Corresponds to the T wave on the surface ECG. Class III antiarrhythmics (amiodarone, sotalol) block K + K^+ K + channels, prolonging Phase 3 and the QT interval.
Phase 4 ; (Resting Membrane Potential) Stable baseline potential maintained at − 90 mV -90\text{ mV} − 90 mV . Maintained by Inward Rectifier K + K^+ K + Channels ( I K 1 I_{K1} I K 1 ) and the ATP-dependent N a + / K + Na^+/K^+ N a + / K + ATPase Pump ( 3 N a + 3\ Na^+ 3 N a + pumped out for every 2 K + 2\ K^+ 2 K + pumped in). Corresponds to electrical diastole (the isoelectric baseline between T wave and subsequent P wave).
Absolute vs. Relative Refractory Periods:
Absolute Refractory Period (ARP / ERP): Spans from Phase 0 through the midpoint of Phase 3. The cardiac cell cannot be re-excited by any electrical stimulus, no matter how strong, because voltage-gated fast N a + Na^+ N a + channels are completely inactivated. This prevents tetanic lockup and retrograde excitation.
Relative Refractory Period (RRP): Occurs during the terminal half of Phase 3 (coinciding with the downslope of the T wave on the ECG). Some N a + Na^+ N a + channels have reset. A suprathreshold electrical impulse (or leakage current > 10 μ A >10\ \mu\text{A} > 10 μ A from a defective medical device) can trigger a disorganized, fragmented action potential, inducing R-on-T lethal Ventricular Fibrillation .
7. Clinical Engineering Relevance: Defibrillators & Pacemakers
Biomedical technicians service, test, and calibrate therapeutic cardiac instrumentation that directly manipulates cellular electrophysiology.
Synchronized Cardioversion vs. Unsynchronized Defibrillation
Unsynchronized Defibrillation (Asynchronous): Delivers a high-energy biphasic shock ( 120 – 360 Joules 120\text{--}360\text{ Joules} 120 – 360 Joules ) instantly upon depressing the shock button. Used only for pulseless rhythms: Ventricular Fibrillation (VF) and Pulseless Ventricular Tachycardia (pVT) .
Synchronized Cardioversion: Used for unstable tachyarrhythmias with a pulse (Atrial Fibrillation, Atrial Flutter, Ventricular Tachycardia with pulse). The defibrillator's internal microcomputer senses the patient's ECG, analyzes the waveform, and places a sync marker flag on the peak of the R-wave . When the operator presses the shock button, the device delays capacitor discharge until the exact millisecond of the next R-wave peak, ensuring current delivery occurs away from the vulnerable Phase 3 repolarization (T-wave), thereby preventing shock-induced VFib.
External Pacemakers & Sensing Kinetics
Demand Pacing (VVI, DDD): Pacing pulse generators continuously monitor intrinsic cardiac bioelectric signals. The BMET tests the Sensing Threshold (measured in millivolts, mV \text{mV} mV ) and Pacing Output Voltage/Current (measured in Volts, V \text{V} V , or milliamperes, mA \text{mA} mA , over a pulse duration of 0.5 – 1.5 ms 0.5\text{--}1.5\text{ ms} 0.5 – 1.5 ms ). If the device's sensing amplifier is set too insensitive (high mV threshold), it will fail to sense intrinsic R-waves ( undersensing ), resulting in competitive asynchronous pacing and potential R-on-T discharge.